Feed 3692.HK
36

Hansoh Pharmaceutical Group Company Limited 3692.HK HKSE · Healthcare · China

$32.62 -0.24% -$0.08

Market cap
¥169.0B
Enterprise value
¥168.6B
P/E
25.3x
Forward P/E
25.4x
PEG
1.1x
P/S
10.6x
P/FCF
27.9x
EV/EBITDA
26.6x
ROIC
12.0%
Gross margin
90.5%
Net margin
42.0%
Dividend yield
1.48%
Payout ratio
37.5%
Net debt/EBITDA
-0.1x
Beta
0.54
Free float
20.4%

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Hui Juan Zhong

Employees

9,643

Headquarters

Shanghai

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Earnings per share grew by 28% a year over the last 3 years.
  • What speaks for it: Analysts expect revenue to grow by 15% this fiscal year.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 CNY of revenue, 42 CNY is left as net profit.

Financial health

Can it carry its debt?

  • What speaks for it: It holds more cash than debt: ¥4.66B against ¥4.23B.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy